4-Aminobiphenyl is a human bladder carcinogen present in many environmental
sources, including cigarette smoke. It can be metabolized in two steps to
the mutagen N-hydroxy-N-acetyl-4-aminobiphenyl (N-OH-AABP). In this study t
he mutational spectrum of N-OH-AABP-exposed human lymphoblastoid cells (TK6
) was determined using HPRT as the target gene. Three large, HAT (hypoxanth
ine-aminopterin-thymidine)-cleaned TK6 cultures were independently treated
with 20 muM N-OH-AABP for 24 h, allowed to recover for 4 days, then continu
ously exposed to 40 muM 6-thioguanine to select for induced mutants. Contem
porary control cultures received vehicle in place of N-OH-AABP. N-OH-AABP t
reatment gave an 11-fold increase in mutation frequency. Mutations were del
ineated in exon 3 of the HPRT gene directly from genomic DNA extracted from
both treated and untreated cells using the polymerase chain reaction, dena
turing gradient gel electrophoresis (DGGE) and dideoxy sequencing. DGGE ana
lysis showed N-OH-AABP increased both the number and type of mutations as c
ompared with controls. The major background mutation was a G(197) --> A tra
nsition. The major N-OH-AABP-induced changes were G(209-211) --> T transver
sions (30 %), a seven-base repeat at position 185 (17 %) and an A(215) -->
T transversion (2 %). The shift in the control spectrum of a transition to
that of transversions and insertions suggest that the electrophile N-OH-AAB
P forms bulky adducts at the same sites on exon 3 of HPRT as do many other
bulky electrophiles, causes replication errors by similar mechanisms, but i
nduces at least one potentially signature mutation.